The RTX toxins of Gram-negative bacterial pathogens: Modulators of the host immune system

Reviews and Research in Medical Microbiology

Volumn 7, Issue 1, 1996, Pages 53-62

  Coote, J G ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cytolysin; Gram negative bacteria; Pore formation; Virulence factor

Indexed keywords

BACTERIAL TOXIN; CYTOLYSIN; NONAPEPTIDE; VIRULENCE FACTOR;

ANTIGEN PRESENTATION; CALCIUM BINDING; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CHANNEL GATING; CONCENTRATION RESPONSE; CYTOLYSIS; EFFECTOR CELL; ENDOTHELIUM CELL; ERYTHROCYTE; GRAM NEGATIVE BACTERIUM; GRANULOCYTE; HUMORAL IMMUNITY; IMMUNOMODULATION; INFLAMMATION; LEUKOCYTE; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MAMMAL CELL; MONOCYTE; PRIORITY JOURNAL; REVIEW; TARGET CELL; TISSUE INJURY;

EID: 0030021314     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013542-199601000-00006     Document Type: Review

References (50)

1. Strathdee CA, Lo RYC. Cloning, nucleotide sequence and characterisation of genes encoding the secretion function of the Pasteurella haemolytica leukotoxin determinant. J Bacteriol 1989; 171: 916-928.
2. Welch RA. Pore-forming cytolysins of Gram-negative bacteria. Mol Microbiol 1991; 5: 521-528.
3. Coote JG. Structural and functional relationships among the RTX toxins of Gram-negative bacteria. FEMS Microbiol Rev 1992; 88: 137-162.
4. Cavalieri SJ, Bohach GA, Snyder IS. Escherichia coli α-hemolysin: characteristics and probable role in pathogenicity. Microb Rev 1984; 48: 326-343.
5. Frey J, Bosse JT, Chang Y-F et al. Actinobacillus pleuropneumoniae RTX toxins: uniform designation of haemolysins, cytolysins, pleurotoxin and their genes. J Gen Microbiol 1993; 139: 1723-1728.
6. Boehm DF, Welch RA, Snyder IS. Domains of Escherichia coli hemolysin (HlyA) involved in binding of calcium and erythrocyte membranes. Infect Immun 1990; 58: 1959-1964.
7. Issartel J-P, Koronakis V, Hughes C. Activation of Escherichia coli prohemolysin to the mature toxin by acyl carrier protein-dependent fatty acylation. Nature 1991; 351: 759-761.
8. Hughes C, Stanley P, Koronakis V. E. coli hemolysin interactions with prokaryotic and eukaryotic cell membranes. Bioessays 1992; 14: 519-525.
9. Ortiz-Carranza O, Czuprynski CJ. Activation of bovine neutrophils by Pasteurella haemolytica leukotoxin is calcium dependent. J Leuk Biol 1992; 52: 558-564.
10. Moayeri M, Welch RA. Effects of temperature, time and toxin concentration on lesion formation by the Escherichia coli hemolysin. Infect Immun 1994; 62: 4124-4134.
11. Zambon JJ. Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol 1985; 12: 1-20.
12. Welch RA, Dellinger EP, Minshew B, Falkow S. Haemolysin contributes to virulence of extraintestinal E. coli infections. Nature 1981; 294: 665-667.
13. Weis AA, Hewlett EL, Myers GA, Falkow S. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis. J Infect Dis 1984; 150: 219-222.
14. Petras SF, Chidambaram M, Illyes EF, Froshauer S, Weinstock GM, Reese CP. Antigenic and virulence properties of Pasteurella haemolytica leukotoxin mutants. Infect Immun 1995; 63: 1033-1039.
15. Bhakdi S, Greulich S, Muhly M et al. Potent leukocidal action of Escherichia coli hemolysin mediated by permeabilisation of target cell membranes. J Exp Med 1989; 169: 737-754.
16. Breider MA, Kumar S, Corstvet RE. Bovine pulmonary epithelial cell damage mediated by Pasteurella haemolytica pathogenic factors. Infect Immun 1990; 58: 1671-1677.
17. Maheswaran SK, Kannan MS, Weiss DJ et al. Enhancement of neutrophil-mediated injury to bovine pulmonary epithelial cells by Pasteurella haemolytica leukotoxin. Infect Immun 1993; 61: 2618-2625.
18. Breider MA, Walker RD, Hopkins FM, Schultz TW, Bowersock TL. Pulmonary lesions induced by Pasteurella haemolytica in neutrophil sufficient and neutrophil deficient calves. Can J Vet Res 1988; 52: 205-209.
19. Janson RJ, Briaire J, Smith HE et al. Knockout mutants of Actinobacillus pleuropneumoniae serotype 1 that are devoid of RTX toxins do not activate or kill porcine neutrophils. Infect Immun 1995; 63: 27-37.
20. Guiso N, Rocancourt M, Szatanik M, Alonso JM. Bordetella adenylate cyclase is a virulence associated factor and a protective antigen. Microb Path 1989; 7: 373-380.
21. Friedman RL, Nordensson K, Wilson L, Akporiaye ET, Yocum DE. Uptake and intracellular survival of Bordetella pertussis in human macrophages. Infect Immun 1992; 60: 4578-4585.
22. Taichman NS, Simpson DL, Sakurada S, Cranfield M, DiRienzo J, Slots J. Comparative studies on the biology of Actinobacillus actinomycetemcomitans leukotoxin in primates. Oral Microb Immunol 1987; 2: 97-104.
23. Mangan DF, Taichman NS, Lally ET, Wahl SM. Lethal effects of Actinobacillus actinomycetemcomitans leukotoxin on human T lymphocytes. Infect Immun 1991; 59: 3267-3272.
24. Jonas D, Schultheis B, Klas C, Krammer PH, Bhakdi S. Cytocidal effects of Escherichia coli hemolysin on human T lymphocytes. Infect Immun 1993; 61: 1715-1721.
25. Shewen PE, Wilkie BN. Cytotoxin of Pasteurella haemolytica acting on bovine leukocytes. Infect Immun 1982; 35: 91-94.
26. Khelef N, Zychlinsky A, Guiso N. Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin. Infect Immun 1993; 61: 4064-4071.
27. Bhakdi S, Martin E. Superoxide generation by human neutrophils induced by low doses of Escherichia coli hemolysin. Infect Immun 1991; 59: 2955-2962.
28. Czuprynski CJ, Noel EJ, Ortiz-Carranza O, Srikumaran S. Activation of bovine neutrophils by Pasteurella haemolytica leukotoxin. Infect Immun 1991; 59: 3126-3133.
29. Dom P, Haessebrouck F, Kamp EM, Smits MA. Influence of Actinobacillus pleuropneumoniae serotype 2 and its cytolysins on porcine neutrophil chemiluminescence. Infect Immun 1992; 60: 4328-4334.
30. 4 and 5-hydroxyeicosatetraenoic acid by bovine polymorphonuclear leukocytes. Infect Immun 1992; 60: 3238-3243.
31. Konig B, Ludwig A, Goebel W, Konig W. Pore formation by the Escherichia coli alpha-hemolysin: role for mediator release from human inflammatory cells. Infect Immun 1994; 62: 4611-4617.
32. Bhakdi S, Muhly M, Korom S, Schmidt G. Effects of Escherichia coli hemolysin on human monocytes: cytocidal action and stimulation of interleukin 1 release. J. Clin Invest 1990; 85: 1746-1753.
33. Yoo HS, Rajagopal BS, Maheswaran SK, Ames TR. Purified Pasteurella haemolytica leukotoxin induces expression of inflammatory cytokines from bovine alveolar macrophages. Microb Path 1995; 18: 237-252.
34. Pace LW, Kreeger JM, Bailey KL, Turnquist SE, Fales WH. Serum levels of tumor necrosis factor α in calves experimentally infected with Pasteurella haemolytica A1. Vet Immunol Immunopath 1993; 35: 353-364.
35. Stevens P, Czuprynski CJ. Dissociation of cytolysis and monokine release by bovine mononuclear phagocytes incubated with Pasteurella haemolytica partially purified leukotoxin and lipopolysaccaride. Can J Vet Res 1995; 59: 110-117.
36. Grimminger F, Sibelius U, Bhakdi S, Suttorp N, Seeger W. Escherichia coli hemolysin is a potent inducer of phosphoinositide hydroysis and related metabolic responses in human neutrophils. J Clin Invest 1991; 88: 1531-1539.
37. Czuprynski CJ, Ortiz-Carranza O. Pasteurella haemolytica leukotoxin inhibits mitogen-induced bovine peripheral blood mononuclear cell proliferation in vitro. Microb Path 1992; 12: 459-463.
38. Majury AL, Shewen PE. The effects of Pasteurella haemolytica leukotoxic culture supernatant on the in vitro proliferative response of bovine lymphocytes. Vet Immunol Immunopath 1991; 29: 41-56.
39. Rabie G, Lally ET, Shenker BC. Immunosuppressive properties of Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun 1988; 56: 122-127.
40. Hughes HPA, Campos M, McDougall L, Beskorwayne TK, Potter AA, Babuik LA. Regulation of major histocompatability class II expression by Pasteurella haemolytica leukotoxin. Infect Immun 1994; 62: 1609-1615.
41. Suttorp N, Floer B, Schnittler H, Seeger W, Bhakdi S. Effects of Escherichia coli hemolysin on endothelial cell function. Infect Immun 1990; 58: 3796-3801.
42. Seeger W, Walter H, Suttorp N, Muhly M, Bhakdi S. Thromboxane-mediated hypertension and vascular leakage evoked by low doses of Escherichia coli alpha-hemolysin in rabbit lungs. J Clin Invest 1989; 84: 220-227.
43. Yoo HS, Maheswaran SK, Lin G, Townsend EL, Ames TR. Induction of inflammatory cytokines in bovine alveolar macrophages following stimulation with Pasteurella haemolytica lipopolysaccharide. Infect Immun 1995; 63: 381-388.
44. Welch RA. Holistic perspective on the Escherichia coli hemolysin. In: Miller VL, Kaper JB, Portnoy DA, Isberg RR, eds. Molecular genetics of bacterial pathogenesis. Washington DC: American Society for Microbiology, 1994: 351-364.
45. Puohiniemi R, Muotiala A, Helander IM, Sarvas M. Conformation of Escherichia coli outer membrane protein OmpA produced in Bacillus subtilis: influence of lipopolysaccharide. FEMS Microb Letts 1993; 106: 105-110.
46. Walmrath D, Ghofrani HA, Rosseau S, et al. Endotoxin 'priming' potentiates lung vascular abnormalities in response to Escherichia coli hemolysin: an example of synergism between endo- and exotoxin. J Exp Med 1994; 180: 1437-1443.
47. Murphy GL, Whitworth LC, Clinkenbeard KD, Clinkenbeard PA. Hemolytic activity of the Pasteurella haemolytica leukotoxin. Infect Immun 1995; 63: 3209-3212.
48. Lally ET, Golub EE, Kieba IR. Identification and immunological characterisation of the domain of Actinobacillus actinomycetemcomitans leukotoxin that determines its specificity for human target cells. J Biol Chem 1994; 49: 31 289-31 295.
49. Forestier C, Welch RA. Identification of RTX toxin target cell specificity domains by use of hybrid genes. Infect Immun 1991; 59: 4212-4220.
50. McWhinney DR, Chang Y-F, Young R, Struck DK. Separable domains define target cell specificities of an RTX hemolysin from Actinobacillus pleuropneumoniae. J. Bacteriol 1992; 174: 291-297.